8th Conference on Retroviruses and Opportunistic Infections Lopinavir/Ritonavir Index



Medical Advocates for Social Justice
Kaletra Library Service Conference Abstracts and Posters

	Index of Abstracts and Posters from 8th Conference on Retroviruses and Opportunistic Infections. Chicago, IL USA
	February 04 - February 08, 2001

KLS Main Page KLS Conference Index Home

Last updated: December 22, 2005

Special Reports

CONFERENCE POSTER
Results from the Kaletra Early Access Program
Reitmayer R, Rode R, Bernstein B, et al
Poster Abstract

In Vitro Studies

CONFERENCE POSTER
Protein Binding of Lopinavir (LPV) and Ritonavir (RTV): In Vitro and Ex Vivo
Data from HIV-infected Patients and Healthy Volunteers
Hsu A, Bertz R, Hickman D, et al
Poster Abstract

Resistance

CONFERENCE POSTER
Patterns of Protease Inhibitor Cross Resistance in Viral Isolates with Reduced
Susceptibility to Lopinavir
Brun S, Kempf D, Isaacson J, et al.
Poster Abstract

CONFERENCE POSTER
Absence of Resistance to Lopinavir/r (formerly known as ABT-378/r) Observed
Through 48 Weeks of Therapy in Antiretroviral-Naīve Subjects (M98-863 Study)
Bernstein B, Moseley J, Kempf D, et al.
Poster Abstract

Viral Dynamics/Response

Using Viral Dynamics To Document the Greater Antiviral Potency of a
Regimen Containing Lopinavir/Ritonavir, Efavirenz, Tenofovir, and
Lamivudine Relative to Standard HAART.
Louie M, Ramratnam B, Kost R, et al
Abstract

Latent Reservoir and Residual HIV-1 Replication on Antiretroviral Therapy
Ho D, Ramratnam B, Louiie M, Markowitz, M
Abstract

Pediatric Treatment Indications

LPV/RTV

Kaletra (ABT-378/ritonavir) in HIV-Infected Children at 48 Weeks
Saez-Llorens X, Renz C, Deetz C,
Abstract

CONFERENCE POSTER
Kaletra (ABT-378/ritonavir) in HIV-Infected Children at 60 Weeks
Saez-Llorens X, Renz C, Deetz C, et al.
Poster

Adolescent/Adult Treatment Indications

LPV/RTV vs NFV in ART-Naīve Patients

CONFERENCE POSTER
Comparison of Time to Achieve HIV RNA <400 copies/mL and <50
copies/mL in a Phase III, Blinded, Randomized Clinical Trial of Kaletra vs.
NFV in ARV-Naīve Patients
King M, Bernstein B, Kempf D, et al
Poster Abstract

LPV/RTV/EFV in Multiple PI-Experienced/NNRTI-Naive Patients

CONFERENCE PRESENTATION
Kaletra (ABT-378/ritonavir) and Efavirenz: 48-Week Safety/Efficacy/Pharmacokinetic Evaluation in Multiple PI-Experienced Patients
Clumeck N, Brun S, Sylte J, et al.
Oral Presentation Abstract

KLS Main Page KLS Conference Index Home

8th Conference on Retroviruses and Opportunistic Infections
KLS Index
Š 2001/2002 Medical Advocates for Social Justice